Randy McIntosh is professor and BC leadership chair in neuroscience and technology transfer across the lifespan, and director of the Institute for Neuroscience and Neurotechnology, at Simon Fraser University. He holds a Ph.D. in psychology and neuroscience with a strong background in statistics. His research journey began at the Rotman Research Institute at the University of Toronto, where he developed a keen interest in understanding aging and cognition. McIntosh is the co-lead for the team that created The Virtual Brain (thevirtualbrain.org), a groundbreaking platform that unites global research efforts.
Randy McIntosh
Director, Institute for Neuroscience and Neurotechnology
Simon Fraser University
Selected articles
- “Partial least squares analysis of neuroimaging data: Applications and advances” | NeuroImage
- “Contexts and catalysts: A resolution of the localization and integration of function in the brain” | Neuroinformatics
- “Emerging concepts for the dynamical organization of resting-state activity in the brain” | Nature Reviews Neuroscience
- “Resting brains never rest: Computational insights into potential cognitive architectures” | Trends in Neurosciences
- “The hidden repertoire of brain dynamics and dysfunction” | Network Neuroscience
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.